Non-specific adsorption of complement proteins affects complement activation pathways of gold nanomaterials
暂无分享,去创建一个
[1] G. Frens. Controlled Nucleation for the Regulation of the Particle Size in Monodisperse Gold Suspensions , 1973 .
[2] E. Brown,et al. Complement activation. , 1981, Immunology today.
[3] P. Kremsner,et al. Mannose-binding lectin plasma levels and gene polymorphisms in Plasmodium falciparum malaria. , 1998, The Journal of infectious diseases.
[4] Jinhua Lu,et al. Human l‐ficolin: plasma levels, sugar specificity, and assignment of its lectin activity to the fibrinogen‐like (FBG) domain , 1998, FEBS letters.
[5] T. Fujita,et al. Cutting Edge: Complement-Activating Complex of Ficolin and Mannose-Binding Lectin-Associated Serine Protease1 , 2000, The Journal of Immunology.
[6] V. Ferriani,et al. Ontogeny of Complement Regulatory Proteins – Concentrations of Factor H, Factor I, C4b‐Binding Protein, Properdin and Vitronectin in Healthy Children of Different Ages and in Adults , 2003, Scandinavian journal of immunology.
[7] F M Muggia,et al. Complement activation following first exposure to pegylated liposomal doxorubicin (Doxil): possible role in hypersensitivity reactions. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.
[8] 小林 邦彦. Mannose binding lectin (MBL) : 最近の知見 , 2003 .
[9] Kazunori Kataoka,et al. PEGylated nanoparticles for biological and pharmaceutical applications. , 2003, Advanced drug delivery reviews.
[10] Stephen Tomlinson,et al. Complement receptor 2-mediated targeting of complement inhibitors to sites of complement activation. , 2003, The Journal of clinical investigation.
[11] J. M. Harris,et al. Effect of pegylation on pharmaceuticals , 2003, Nature Reviews Drug Discovery.
[12] T. Hartung,et al. L-Ficolin Specifically Binds to Lipoteichoic Acid, a Cell Wall Constituent of Gram-Positive Bacteria, and Activates the Lectin Pathway of Complement 1 , 2004, The Journal of Immunology.
[13] T. Fujita,et al. Human Mannose-binding Lectin and l-Ficolin Function as Specific Pattern Recognition Proteins in the Lectin Activation Pathway of Complement* , 2004, Journal of Biological Chemistry.
[14] R. Nisihara,et al. Significantly increased levels of mannose‐binding lectin (MBL) in rheumatic heart disease: a beneficial role for MBL deficiency , 2004, Clinical and experimental immunology.
[15] Francesco M Veronese,et al. PEGylation, successful approach to drug delivery. , 2005, Drug discovery today.
[16] Janos Szebeni,et al. Complement activation-related pseudoallergy: a new class of drug-induced acute immune toxicity. , 2005, Toxicology.
[17] C. Cudrici,et al. The role of the complement system in innate immunity , 2005, Immunologic research.
[18] Malcolm L. H. Green,et al. Complement activation and protein adsorption by carbon nanotubes. , 2006, Molecular immunology.
[19] Younan Xia,et al. Gold nanostructures: engineering their plasmonic properties for biomedical applications. , 2006, Chemical Society reviews.
[20] T. Fujita,et al. Lectin complement system and pattern recognition. , 2006, Immunobiology.
[21] T. Kuijpers,et al. High prevalence of mannose‐binding lectin (MBL) deficiency in premature neonates , 2006, Clinical and experimental immunology.
[22] Arezou A Ghazani,et al. Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. , 2006, Nano letters.
[23] T. Ross,et al. Complement-mediated activation of the adaptive immune responses , 2006, Immunologic research.
[24] P. Jain,et al. Gold nanoparticles: interesting optical properties and recent applications in cancer diagnostics and therapy. , 2007, Nanomedicine.
[25] B. Hansen,et al. Ficolin-2 recognizes DNA and participates in the clearance of dying host cells. , 2007, Molecular immunology.
[26] M. Boermeester,et al. Low Serum Mannose-Binding Lectin Level Increases the Risk of Death due to Pneumococcal Infection , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[27] Malcolm L. H. Green,et al. Effects of covalent functionalization on the biocompatibility characteristics of multi-walled carbon nanotubes. , 2008, Journal of nanoscience and nanotechnology.
[28] Naomi J Halas,et al. Nanoshell-enabled photothermal cancer therapy: impending clinical impact. , 2008, Accounts of chemical research.
[29] E. Esenturk,et al. Surface-enhanced Raman scattering spectroscopy via gold nanostars , 2009 .
[30] Malini Olivo,et al. Control of optical contrast using gold nanoshells for optical coherence tomography imaging of mouse xenograft tumor model in vivo. , 2009, Journal of biomedical optics.
[31] S. Hsu,et al. Cytotoxicity and immunological response of gold and silver nanoparticles of different sizes. , 2009, Small.
[32] R. H. Scofield,et al. Systemic lupus erythematosus and C1q: A quantitative ELISA for determining C1q levels in serum. , 2009, Biotechnology journal.
[33] Darren J. Martin,et al. Differential plasma protein binding to metal oxide nanoparticles , 2009, Nanotechnology.
[34] M. Matsushita,et al. L-ficolin (ficolin-2) insufficiency is associated with combined allergic and infectious respiratory disease in children. , 2009, Molecular immunology.
[35] J. Jensenius,et al. Mannose-Binding Lectin (MBL) Substitution: Recovery of Opsonic Function In Vivo Lags behind MBL Serum Levels1 , 2009, The Journal of Immunology.
[36] Q. Hu,et al. Specifically Binding of L-ficolin to N-glycans of HCV Envelope Glycoproteins E1 and E2 Leads to Complement Activation , 2009, Cellular and Molecular Immunology.
[37] S. Libutti,et al. Results of a completed phase I clinical trial of CYT-6091: A pegylated colloidal gold-TNF nanomedicine. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[38] Parag Aggarwal,et al. Interaction of colloidal gold nanoparticles with human blood: effects on particle size and analysis of plasma protein binding profiles. , 2009, Nanomedicine : nanotechnology, biology, and medicine.
[39] Lawrence Tamarkin,et al. Phase I and Pharmacokinetic Studies of CYT-6091, a Novel PEGylated Colloidal Gold-rhTNF Nanomedicine , 2010, Clinical Cancer Research.
[40] John D Lambris,et al. Complement: a key system for immune surveillance and homeostasis , 2010, Nature Immunology.
[41] Wen-chao Song,et al. Complement and its role in innate and adaptive immune responses , 2010, Cell Research.
[42] D. Hourcade,et al. Properdin: emerging roles of a pattern-recognition molecule. , 2010, Annual review of immunology.
[43] Hendrik Engelbrecht,et al. Radioactive gold nanoparticles in cancer therapy: therapeutic efficacy studies of GA-198AuNP nanoconstruct in prostate tumor-bearing mice. , 2010, Nanomedicine : nanotechnology, biology, and medicine.
[44] C. Sharma,et al. Blood protein adsorption and compatibility studies of gold nanoparticles , 2011 .
[45] Istvan Toth,et al. Nanoparticle-induced unfolding of fibrinogen promotes Mac-1 receptor activation and inflammation. , 2011, Nature nanotechnology.
[46] Davoud Ahmadvand,et al. Material properties in complement activation. , 2011, Advanced drug delivery reviews.
[47] A. Popovtzer,et al. Targeted gold nanoparticles enable molecular CT imaging of cancer: an in vivo study , 2011, International journal of nanomedicine.
[48] J. Lausmaa,et al. Immune complement activation is attenuated by surface nanotopography , 2011, International journal of nanomedicine.
[49] Willi Paul,et al. Green synthesis of gold nanoparticles with Zingiber officinale extract: Characterization and blood compatibility , 2011 .
[50] M. Tóth,et al. In vitro and in vivo complement activation and related anaphylactic effects associated with polyethylenimine and polyethylenimine-graft-poly(ethylene glycol) block copolymers. , 2011, Biomaterials.
[51] Rodney F. Minchin,et al. Molecular interaction of poly(acrylic acid) gold nanoparticles with human fibrinogen. , 2012, ACS nano.
[52] D. Fraser,et al. Complement activation and cell uptake responses toward polymer-functionalized protein nanocapsules. , 2012, Biomacromolecules.
[53] Gwo-Bin Lee,et al. Size-Dependent Attenuation of TLR9 Signaling by Gold Nanoparticles in Macrophages , 2012, The Journal of Immunology.
[54] Yechezkel Barenholz,et al. Liposome-induced complement activation and related cardiopulmonary distress in pigs: factors promoting reactogenicity of Doxil and AmBisome. , 2012, Nanomedicine : nanotechnology, biology, and medicine.
[55] James Chen Yong Kah,et al. Exploiting the protein corona around gold nanorods for loading and triggered release. , 2012, ACS nano.
[56] Glenn P. Goodrich,et al. Evaluation of the Toxicity of Intravenous Delivery of Auroshell Particles (Gold–Silica Nanoshells) , 2012, International journal of toxicology.
[57] Ming-hui Zhao,et al. Serum levels and renal deposition of C1q complement component and its antibodies reflect disease activity of lupus nephritis , 2013, BMC Nephrology.
[58] Chun Xing Li,et al. Pharmacokinetics, clearance, and biosafety of polyethylene glycol-coated hollow gold nanospheres , 2014, Particle and Fibre Toxicology.
[59] J. Kah. Stability and aggregation assays of nanoparticles in biological media. , 2013, Methods in molecular biology.
[60] D. Cliffel,et al. In vivo toxicity, biodistribution, and clearance of glutathione-coated gold nanoparticles. , 2013, Nanomedicine : nanotechnology, biology, and medicine.
[61] Mingwu Shen,et al. Folic acid-modified dendrimer-entrapped gold nanoparticles as nanoprobes for targeted CT imaging of human lung adencarcinoma. , 2013, Biomaterials.
[62] Zhe Wang,et al. Single Continuous Wave Laser Induced Photodynamic/Plasmonic Photothermal Therapy Using Photosensitizer‐Functionalized Gold Nanostars , 2013, Advanced materials.
[63] Thomas J. Anchordoquy,et al. Questioning the use of PEGylation for drug delivery , 2013, Drug Delivery and Translational Research.
[64] Hongjie Dai,et al. Single-walled carbon nanotube surface control of complement recognition and activation. , 2013, ACS nano.
[65] T. Andresen,et al. Complement activation by PEG-functionalized multi-walled carbon nanotubes is independent of PEG molecular mass and surface density. , 2013, Nanomedicine : nanotechnology, biology, and medicine.
[66] Rodney F. Minchin,et al. Plasma protein binding of positively and negatively charged polymer-coated gold nanoparticles elicits different biological responses , 2012, Nanotoxicology.
[67] Fabrizio Mancin,et al. Factors affecting T cell responses induced by fully synthetic glyco-gold-nanoparticles. , 2013, Nanoscale.
[68] T. Mészáros,et al. Features of complement activation-related pseudoallergy to liposomes with different surface charge and PEGylation: comparison of the porcine and rat responses. , 2014, Journal of controlled release : official journal of the Controlled Release Society.
[69] Anil K Patri,et al. Protein corona composition does not accurately predict hematocompatibility of colloidal gold nanoparticles. , 2014, Nanomedicine : nanotechnology, biology, and medicine.
[70] T. Anchordoquy,et al. Potential induction of anti-PEG antibodies and complement activation toward PEGylated therapeutics. , 2014, Drug discovery today.
[71] Robert B Sim,et al. Complement activation by carbon nanotubes and its influence on the phagocytosis and cytokine response by macrophages. , 2014, Nanomedicine : nanotechnology, biology, and medicine.
[72] John D Lambris,et al. Mediation of a non-proteolytic activation of complement component C3 by phospholipid vesicles. , 2014, Biomaterials.
[73] Seyed Moein Moghimi,et al. Mechanisms of complement activation by dextran-coated superparamagnetic iron oxide (SPIO) nanoworms in mouse versus human serum , 2014, Particle and Fibre Toxicology.
[74] E. Conway,et al. Modulation of complement activation and amplification on nanoparticle surfaces by glycopolymer conformation and chemistry. , 2014, ACS nano.
[75] P. Pelicon,et al. Size-Dependent Effects of Gold Nanoparticles Uptake on Maturation and Antitumor Functions of Human Dendritic Cells In Vitro , 2014, PloS one.
[76] M. Ng,et al. Understanding aggregation-based assays: nature of protein corona and number of epitopes on antigen matters , 2015 .
[77] V. Frémeaux-Bacchi,et al. Complement System Part I – Molecular Mechanisms of Activation and Regulation , 2015, Front. Immunol..
[78] T. Fujita,et al. New insights into the role of ficolins in the lectin pathway of innate immunity. , 2015, International review of cell and molecular biology.
[79] S. Lai,et al. Anti-PEG immunity: emergence, characteristics, and unaddressed questions. , 2015, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.
[80] Tracy Vargo-Gogola,et al. Gold nanoparticles as contrast agents in x-ray imaging and computed tomography. , 2015, Nanomedicine.
[81] V. M. Holers,et al. Modulatory Role of Surface Coating of Superparamagnetic Iron Oxide Nanoworms in Complement Opsonization and Leukocyte Uptake. , 2015, ACS nano.
[82] H. Khan,et al. Innate immune humoral factors, C1q and factor H, with differential pattern recognition properties, alter macrophage response to carbon nanotubes. , 2015, Nanomedicine : nanotechnology, biology, and medicine.
[83] J. Kah,et al. Optimizing gold nanostars as a colloid-based surface-enhanced Raman scattering (SERS) substrate , 2015 .
[84] J. Pfau,et al. Selective inhibitory effects of 50-nm gold nanoparticles on mouse macrophage and spleen cells , 2016, Journal of immunotoxicology.
[85] Robert B Sim,et al. Complement Deposition on Nanoparticles Can Modulate Immune Responses by Macrophage, B and T Cells. , 2016, Journal of Biomedical Nanotechnology.
[86] Sung Tae Kim,et al. Regulation of Macrophage Recognition through the Interplay of Nanoparticle Surface Functionality and Protein Corona. , 2016, ACS nano.
[87] C. Murphy,et al. One low-dose exposure of gold nanoparticles induces long-term changes in human cells , 2016, Proceedings of the National Academy of Sciences.
[88] D. Kingston,et al. Synthesis and Evaluation of Paclitaxel-Loaded Gold Nanoparticles for Tumor-Targeted Drug Delivery. , 2016, Bioconjugate chemistry.
[89] R. Shukla,et al. Photothermal therapy mediated by gum Arabic-conjugated gold nanoparticles suppresses liver preneoplastic lesions in mice. , 2016, Journal of photochemistry and photobiology. B, Biology.
[90] K. Soo,et al. Exploiting the protein corona around gold nanorods for low-dose combined photothermal and photodynamic therapy. , 2017, Journal of materials chemistry. B.